SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-083520
Filing Date
2004-05-10
Accepted
2004-05-10 15:05:50
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004 d10q.htm 10-Q 156294
2 MODIFICATION TO COMMERCIAL PROMISSORY NOTE AGREEMENT dex1043.htm EX-10.43 13767
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8988
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9068
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2643
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2721
  Complete submission text file 0001193125-04-083520.txt   195758
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 04792646
SIC: 2834 Pharmaceutical Preparations